Back to User profile » Professor Paul Jones
Papers published by Professor Paul Jones:
A Telemedicine Approach for Monitoring COPD: A Prospective Feasibility and Acceptability Cohort Study
Shinoda M, Hataji O, Miura M, Kinoshita M, Mizoo A, Tobino K, Soutome T, Nishi T, Ishii T, Miller BE, Tal-Singer R, Tomlinson R, Matsuki T, Jones PW, Shibata Y
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2931-2944
Published Date: 17 November 2022
Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial
Halpin DM, Kendall R, Shukla S, Martin A, Shah D, Midwinter D, Beeh KM, Kocks JWH, Jones PW, Compton C, Risebrough NA, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2745-2755
Published Date: 25 October 2022
Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study
Yorke J, Khan N, Garrow A, Tyson S, Singh D, Vestbo J, Jones PW
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2289-2299
Published Date: 15 September 2022
The Development of a COPD Exacerbation Recognition Tool (CERT) to Help Patients Recognize When to Seek Medical Advice
Jones PW, Wang C, Chen P, Chen L, Wang D, Xia J, Yang Y, Wang Y, Ma Q
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:213-222
Published Date: 21 January 2022
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
Shukla S, Shah D, Martin A, Risebrough NA, Kendall R, Vogelmeier CF, Boucot I, Tombs L, Bjermer L, Jones PW, Kerwin E, Compton C, Maltais F, Lipson DA, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3105-3118
Published Date: 13 November 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
Bjermer L, Boucot IH, Maltais F, Kerwin EM, Naya IP, Tombs L, Jones PW, Compton C, Lipson DA, Vogelmeier CF
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1939-1956
Published Date: 28 June 2021
A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design
Hizawa N, Fukunaga K, Sugiura H, Nakano Y, Kato M, Sugiyama Y, Hanazawa T, Kaise T, Tal-Singer R, Jones PW, Barnes N, Compton C, Ishii T
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1813-1822
Published Date: 18 June 2021
Clinical Characteristics of COPD Patients According to COPD Assessment Test (CAT) Score Level: Cross-Sectional Study
Gil HI, Zo S, Jones PW, Kim BG, Kang N, Choi Y, Cho HK, Kang D, Cho J, Park HY, Shin SH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1509-1517
Published Date: 1 June 2021
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
Vogelmeier CF, Naya IP, Maltais F, Bjermer L, Kerwin EM, Tombs L, Jones PW, Compton C, Lipson DA, Boucot IH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1215-1226
Published Date: 3 May 2021
Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD
Bourbeau J, Bafadhel M, Barnes NC, Compton C, Di Boscio V, Lipson DA, Jones PW, Martin N, Weiss G, Halpin DMG
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:499-517
Published Date: 1 March 2021
Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany
Lewis HB, Schroeder M, Gunsoy NB, Janssen EM, Llewellyn S, Doll HA, Jones PW, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:595-604
Published Date: 18 March 2020
Inhaled corticosteroids, blood eosinophils, and FEV1 decline in patients with COPD in a large UK primary health care setting
Whittaker HR, Müllerova H, Jarvis D, Barnes NC, Jones PW, Compton CH, Kiddle SJ, Quint JK
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1063-1073
Published Date: 23 May 2019
Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries
Ishii T, Nishimura M, Akimoto A, James MH, Jones P
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3459-3471
Published Date: 26 October 2018
A randomized trial of symptom-based management in Japanese patients with COPD
Betsuyaku T, Kato M, Fujimoto K, Kobayashi A, Hayamizu T, Hitosugi H, Hagan G, James MH, Jones PW
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2409-2423
Published Date: 13 August 2018
The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world
Barnes N, Ishii T, Hizawa N, Midwinter D, James M, Hilton E, Jones PW
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:433-440
Published Date: 2 February 2018